Beizray Drug Interactions: 486 Major, 198 Moderate
Beizray (Docetaxel) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Beizray. Always confirm against the full prescribing information.
100 interactions
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Docetaxel.
Level 1 evidence
Albendazole
The metabolism of Docetaxel can be decreased when combined with Albendazole.
Level 2 evidence
Alendronic acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Docetaxel.
Level 2 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Docetaxel.
Level 1 evidence
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Docetaxel.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Docetaxel.
Level 1 evidence
Amphotericin B
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Docetaxel.
Level 2 evidence
Anastrozole
The risk or severity of cardiotoxicity can be increased when Anastrozole is combined with Docetaxel.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Docetaxel.
Level 2 evidence
Apalutamide
The serum concentration of Docetaxel can be decreased when it is combined with Apalutamide.
Level 1 evidence
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Docetaxel.
Level 1 evidence
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Docetaxel.
Level 1 evidence
Enter your NPI to unlock 46 major interactions for Beizray
Beizray (Docetaxel) has 970 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Beizray (Docetaxel) has 486 major, 198 moderate, and 286 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Beizray. Always confirm against the full prescribing information.